EFSCE
CHRS icon

Enterprise Financial Services Corp (EFSC)’s Coherus Oncology CHRS Stock Holding History

Enterprise Financial Services Corp (EFSC)’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-58
Closed -$1K – 998
2016
Q1 		$1K Buy
+58
New +$950 ﹤0.01% 958

Other funds holding CHRS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Enterprise Financial Services Corp (EFSC)'s CHRS Position: Q2 2016 in Review

Enterprise Financial Services Corp (EFSC) sold out of Coherus Oncology (CHRS) in Q2 2016, closing a stake of 58 shares — an estimated $1K sold.

Enterprise Financial Services Corp (EFSC) first reported a position in CHRS in Q1 2016 and held it in 1 quarter. The position peaked at $1K in Q1 2016. 86 funds tracked by Wall St. Rank hold CHRS as of Q2 2016.

  • Enterprise Financial Services Corp (EFSC) reported no remaining Coherus Oncology position as of Q2 2016 after selling out during the quarter.
  • Enterprise Financial Services Corp (EFSC) sold 58 Coherus Oncology shares in Q2 2016, an estimated $1K.
  • Enterprise Financial Services Corp (EFSC) first reported a position in Coherus Oncology in Q1 2016 and held it in 1 quarter.
  • Enterprise Financial Services Corp (EFSC)'s Coherus Oncology position peaked at $1K in Q1 2016.
  • 86 funds tracked by Wall St. Rank held Coherus Oncology as of Q2 2016.

Based on Enterprise Financial Services Corp (EFSC)'s 13F filing for Q2 2016, filed 29 Jul 2016.